GlaxoSmithKline S.A.E (EGX:BIOC)

Market Cap	5.29B
Revenue (ttm)	3.74B
Net Income (ttm)	98.36M
Shares Out	83.51M
EPS (ttm)	1.17
PE Ratio	54.06
Forward PE	n/a
Dividend	0.75 (1.18%)
Ex-Dividend Date	n/a

Volume	22,995
Average Volume	73,053
Open	63.00
Previous Close	63.00
Day's Range	62.70 - 63.99
52-Week Range	32.66 - 81.50
Beta	0.98
RSI	40.31
Earnings Date	Nov 13, 2025

About GlaxoSmithKline S.A.E

GlaxoSmithKline S.A.E. engages in production of pharmaceutical chemicals. The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E. was founded in 1981 and is based in London, the United Kingdom. GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.

• Industry: Pharmaceutical Preparations
• Founded: 1981
• Employees: 800
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: BIOC

Financial Performance

In 2024, GlaxoSmithKline S.A.E's revenue was 2.99 billion, an increase of 33.51% compared to the previous year's 2.24 billion. Earnings were 173.98 million, an increase of 187.78%.